Vertex Pharma.


Cambridge biotech company Vertex Pharmaceuticals Inc. paid its departing chief executive, Matthew W. Emmens, $13.3 million last year, down from $14.9 million in 2010, according to a regulatory filing. His compensation included a $1.1 million salary, an incentive plan payment of $3 million, and stock and option grants totaling $9.1 million. He stepped down Feb. 1. Jeffrey Leiden took over the job.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of